AJIC: American Journal of Infection Control
Volume 37, Issue 9 , Pages 723-728 , November 2009

Epidemiology of an outbreak of antibiotic-resistant Klebsiella pneumoniae at a tertiary care medical center

  • Alina Filozov, DO

      Affiliations

    • Division of Infectious Diseases, New York Medical College, Valhalla, NY
    • ,
  • Paul Visintainer, PhD

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, New York Medical College, Valhalla, NY
    • ,
  • Carol Carbonaro, PhD

      Affiliations

    • Department of Pathology, New York Medical College, Valhalla, NY
    • ,
  • Maria Aguero-Rosenfeld, MD

      Affiliations

    • Department of Pathology, New York Medical College, Valhalla, NY
    • ,
  • Gary P. Wormser, MD

      Affiliations

    • Division of Infectious Diseases, New York Medical College, Valhalla, NY
    • ,
  • Marisa A. Montecalvo, MD

      Affiliations

    • Division of Infectious Diseases, New York Medical College, Valhalla, NY
    • Corresponding Author InformationAddress correspondence to Marisa A. Montecalvo, MD, Division of Infectious Diseases, New York Medical College, Munger Pavilion room 245, Valhalla, NY 10595.

References 

  1. Jacoby GA, Munoz-Price LS. The new β-lactamases. N Engl J Med. 2005;352:380–391
  2. Knothe H, Shah P, Kremery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole, and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcenscens. Infection. 1983;11:315–317
  3. Paterson DL, Ko W-C, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med. 2004;140:26–32
  4. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific Region. Clin Infect Dis. 2001;32(Suppl 2):S94–S103
  5. Owens RC, Rice L. Hospital-based strategies for combating resistance. Clin Infect Dis. 2006;42(Suppl 4):S173–S181
  6. Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280:1233–1237
  7. Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem resistance in New York City: a threat to our antibiotic armamentarium. Arch Intern Med. 2005;165:1430–1435
  8. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–828
  9. Clinical and Laboratory Standards Institute/NCCLS. 2005. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. M100-S15, Vol.25 No. 1. Clinical and Laboratory Standards Institute, Wayne, Pa.
  10. Tenover FC, Arbeit RD, Mickelsen PA, et al. Interpreting chromosomal DNA restriction patterns produced by pulse-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–2239
  11. Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet. 1987;2(8554):302–306
  12. De Champs C, Rouby D, Guelon D, et al. A case-control study of an outbreak of infections caused by Klebsiella pnumoniae strains producing CTX-1 (TEM-3) β-lactamase. J Hosp Infect. 1991;18:5–13
  13. Hobson RP, MacKenzie FM, Gould IM. An outbreak of multiple-resistant Klebsiella pnumoniae in the Grampian region of Scotland. J Hosp Infect. 1996;33:249–262
  14. Lucet J-C, Chevret S, Decre D, et al. Outbreak of multiple-resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis. 1996;22:430–436
  15. Peňa C, Pujol M, Ricart A, et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended-spectrum β-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect. 1997;35:9–16
  16. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med. 1993;119:353–358
  17. D'Agata EM, Venkataraman L, DeGirolami P, Weigel L, Samore M, Tenover F. The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum β-lactamase in a tertiary care hospital. J Infect. 1998;36:279–285
  18. Bisson G, Fishman NO, Patel JB, Edelstein PH, Lautenbach E. Extended-spectrum β-lactamase-producing Escherichia Coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect Control Hosp Epidimiol. 2002;23:254–260
  19. Kim Y-K, Pai H, Lee H-J, et al. Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia Coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antmicrob Agents Chemother. 2002;46:1481–1491
  20. Piroth L, Aube H, Doise J-M, Vicent-Martin M. Spread of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: are β-lactamase inhibitors of therapeutic value?. Clin Infect Dis. 1998;27:76–80
  21. Kang CI, Kim SH, Kim DM, et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2004;25:860–867
  22. Peňa C, Pujol M, Ardanuy C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother. 1998;42:53–58
  23. Schiappa DA, Hayden MK, Matushek MG, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis. 1996;174:529–536
  24. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32:1162–1171
  25. Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic care facility. Antimicrob Agents Chemother. 1990;34:2193–2199
  26. Naumovski L, Quinn JP, Miyashiro D, et al. Outbreak of ceftazidime resistance dueto novel extended-spectrum β-lactamase in isolates from cancer patients. Antimicrob Agents Chemother. 1992;36:1991–1996
  27. Quale JM, Landman D, Bradford PA, et al. Molecular epidemiology of a citywide outbreak of extended spectrum β-lactamase producing Klebsiella pneumoniae infection. Clin Infect Dis. 2002;35:834–841
  28. Asensio A, Oliver A, Gonzalez-Diego P, et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis. 2000;30:55–60
  29. Lee SO, Lee ES, Park SY, Kim SY, Seo YH, Cho YK. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2004;25:832–837
  30. Lin MF, Huang ML, Lai SH. Risk factors in the acquisition of extended-spectrum β-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. J Hosp Infect. 2003;53:39–45
  31. Rice LB, Eckstein EC, Devente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis. 1996;23:118–124
  32. Lipworth AD, Hyle EP, Fishman NO, et al. Limiting the emergence of extended-spectrum β-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Control Hosp Epidemiol. 2006;27:279–286
  33. Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA. 1999;281:517–523
  34. Paterson DL, Ko W-C, Von Gottberg A, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin Infect Dis. 2003;39:31–37
  35. Lucet J-C, Decre D, Fichelle A, et al. Control of a prolonged outbreak of extended-spectrum β-lactamase-producing enterobacteriaceae in a university hospital. Clin Infect Dis. 1999;29:1411–1418

 Conflicts of interest: None to report.

PII: S0196-6553(09)00425-8

doi: 10.1016/j.ajic.2009.02.006

AJIC: American Journal of Infection Control
Volume 37, Issue 9 , Pages 723-728 , November 2009

Article Tools

* Image Usage & Resolution